Identity
- Security key
- 18667
- Ticker
- MNOV
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2006-12-07
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- MNOV
Detail
Enriched 2026-08-14 20:47
- Market cap
- $65,464,257.18
- Shares outstanding (class)
- 49,221,246
- Shares outstanding (weighted)
- 49,221,246
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 6
- Location
- LA JOLLA, CA
- Homepage
- https://www.medicinova.com
- Description
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.